CClinicalTrials.gg
Status unknownNCT04650659Updated May 20, 2022

Functional Exercise Tests in Patients With Systemic Sclerosis

An observational study in Scleroderma, Systemic, Lung Diseases, Interstitial and Pulmonary Arterial Hypertension, sponsored by University of Aarhus. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-20.

Sponsored by University of Aarhus · Observational

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
83
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to examine the validity of peripheral oxygen saturation measurement during the 6-minute walk test in patients with Systemic Sclerosis (SSc) and to examine the utility of two other functional tests as markers of pulmonary involvement in patients with SSc.

Read the detailed description

Systemic Sclerosis (SSc) is a connective tissue disease characterized by progressive organ fibrosis and vascular dysfunction. The leading causes of disease related morbidity and mortality are interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH). The 6-minute walk test (6MWT) is a submaximal functional exercise test used to evaluate ILD and PAH in patients with SSc. Desaturations during the 6MWT have been considered suggestive of ILD and PAH. Still, the optimal method to measure peripheral oxygen saturation during the 6MWT in patients with SSc remains unclear. Furthermore, other functional exercise tests may also be useful in patients with SSc.

Patients with SSc will perform three functional exercise tests, and approximately half of the patients will be invited to repeat the tests 1 week later to determine test-retest reliability. Additionally, nailfold videocapillaroscopy (NVC) will be performed on every patient to assess the capillary density of the nailfold of the fingers. Furthermore, to study the effect of SSc on bone, a high resolution peripheral quantitative computed tomography (HRpQCT) scan of radius and distal interphalangeal joints (DIP)/distal phalanges will be performed.

During the 6MWT, the peripheral oxygen saturation (SpO2) will be measured continuously on three anatomical locations. An arterial line will be placed, and blood will be drawn at baseline and after ended 6MWT and analysed for arterial oxygen saturation (SaO2). The correlation between the capillary density of the nailfold and the SpO2 measured on the finger will be assessed. The correlation between capillary density of the nailfold and bone status in the fingers and distal radius assessed with HRpQCT will be evaluated, and HRpQCT images will be compared with conventional radiography and DEXA. Bland-Altman plot will be used to display the agreement between SaO2 and SpO2 and between the two 6MWT. Further, the association between pulmonary variables and 6MWT results will be examined.

Two alternative functional exercise tests will be investigated and compared to results in the 6MWT: The 1-minute sit-to-stand test (1STST) and the 4-meter gait speed test (4MGS). The association between the three functional exercise tests and clinical parameters in patients with SSc will be examined.

02

Conditions studied

  • Scleroderma, Systemic
  • Lung Diseases, Interstitial
  • Pulmonary Arterial Hypertension
  • Acroosteolysis

Keywords

  • 6-Minute Walk Test
  • Scleroderma, Systemic
  • Oximetry
  • Exercise test
  • Raynaud Disease
  • HR-pQCT
  • Nailfold videocapillaroscopy
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's planned enrollment of 83 is below the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients are recruited if they have a clinical course at the Department of Rheumatology, Aarhus University Hospital (>500 patients with Scleroderma)

Inclusion criteria

  • Diagnosed with Systemic Sclerosis according to the ACR/EULAR 2013 criteria
  • Provided written informed consent

Exclusion criteria

Exclusion Criteria:

  • Overlap syndrome (except for rheumatoid arthritis and Sjögren syndrome)
  • Recent or ongoing lung infection
  • Other major comorbidities that could affect the functional exercise tests.
  • Pregnancy
  • Unable to understand the patient information
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
83 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Part one of the project

    83 patients with Systemic Sclerosis will perform three functional exercise tests on the same day. All 83 patients will be examined with NVC. Moreover, HRpQCT will be performed on all patients at baseline and after 1 year.

    Diagnostic Test: 6-minute walk test part one · Diagnostic Test: 1-minute sit-to-stand test · Diagnostic Test: 4-meters gait speed test · Diagnostic Test: Nailfold videocapillaroscopy · Diagnostic Test: HR-pQCT · Diagnostic Test: Hand x-ray · Diagnostic Test: DEXA

  • Part two of the project

    Half of the patients from part one of the project will be invited to repeat the three functional exercise tests approximately one week later in reverse order to determine test-retest reliability.

    Diagnostic Test: 6-minute walk test part two · Diagnostic Test: 1-minute sit-to-stand test · Diagnostic Test: 4-meters gait speed test

Interventions

  • Diagnostic test6-minute walk test part one

    Measurement of: 6-minute walk distance, the modified Borg scale before and after testing and continuous measure of peripheral oxygen saturation and heart rate. The peripheral oxygen saturation will be measured continuously on three anatomical location: the forehead, an earlobe and a finger. In patients who will accept an arterial line will be placed and blood gas will be analyzed.

  • Diagnostic test6-minute walk test part two

    Measurement of: 6-minute walk distance, the modified Borg scale before and after testing and continuous measure of peripheral oxygen saturation and heart rate. The peripheral oxygen saturation will be measured continuously on three anatomical location: the forehead, an earlobe and a finger. No arterial line will be placed.

  • Diagnostic test1-minute sit-to-stand test

    Measurement of: Number of repetitions, the modified Borg scale before and after testing and continuous measure of peripheral oxygen saturation and heart rate. The peripheral oxygen saturation will be measured on the three anatomical locations mentioned above.

  • Diagnostic test4-meters gait speed test

    Measurement of: Time to complete the 4 meters course and calculation of the 4-meters-gait-speed.

  • Diagnostic testNailfold videocapillaroscopy

    Capillary density measurement of: The finger with the probe and the average of all the fingers. NVC with 200 x magnification will be performed on the 2nd to 5th finger on both hands.

  • Diagnostic testHR-pQCT

    Imaging: One arm is scanned in a 9 mm-long volume of the distal radius (110 slices), and the distal part of the 2nd to 5th finger on both hands are scanned in a 36,08 mm-long volume (440 slices) at baseline and after 1 year.

  • Diagnostic testHand x-ray

    Imaging: Hand x-ray was performed on patients scanned with HR-pQCT, unless images were already available (≤ 1 year).

  • Diagnostic testDEXA

    Imaging: A bone density (DEXA) scan was performed on patients scanned with HR-pQCT, unless it was already available (≤ 2 years).

06

What researchers measure

Primary outcomes

  1. Examine the validity of peripheral oxygen saturation measurement during 6-minute walk test in patients with Systemic Sclerosis.

    The agreement between the peripheral oxygen saturation measured on the forehead, finger and earlobe and the arterial oxygen saturation from the blood gas analysis will be examined.

    Time frame: 1 hour

Secondary outcomes

  1. Examine the correlation between the 6-minute walk test, the 1-minute sit-to-stand test, and the 4-meter gait speed test in patients with Systemic Sclerosis.

    The agreement between the 6-minute walk test, the 1-minute sit-to-stand test, and the 4-meter gait speed test in patients with Systemic Sclerosis.

    Time frame: 1 hour

  2. Investigate the correlation between functional exercise tests and the severity of pulmonary involvement in patients with Systemic Sclerosis.

    The agreement between functional exercise tests and the severity of pulmonary involvement in patients with Systemic Sclerosis.

    Time frame: 1 hour

07

Study locations

1 site
  • The Department of Rheumatology, Aarhus University Hospital
    Aarhus, 8200, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04650659
Lead sponsor
University of Aarhus
Collaborators
The Danish Rheumatism Association
Responsible party
Sponsor
First posted
Dec 3, 2020
Start date
Jul 27, 2021
Primary completion
Jan 31, 2023 (estimated)
Completion
Jan 31, 2023 (estimated)
Last update
May 20, 2022

Study contacts

Klaus Søndergaard, MD, PhD
study chair · Department of Rheumatology, Aarhus University Hospital, DK
Amanda Lynggaard Riis, Student
principal investigator · Department of Rheumatology, Aarhus University Hospital, DK
Esben Uggerby Næser, MD, PhD
study director · Department of Rheumatology, Aarhus University Hospital, DK
Katja Thorup Aaen, Student
principal investigator · Department of Rheumatology, Aarhus University Hospital, DK
Ellen-Margrethe Hauge, Professor
study chair · Department of Rheumatology, Aarhus University Hospital, DK
Frederik Cosedis Enevoldsen, Student
principal investigator · Department of Rheumatology, Aarhus University Hospital, DK
Rasmus Klose Jensen, MD, PhD
study director · Department of Rheumatology, Aarhus University Hospital, DK
Josephine Therkildsen, MD
study director · Department of Rheumatology, Aarhus University Hospital, DK

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion